Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › TN › Brownsville › NPI 1932363074

Clarey R. Dowling, MD, P.C.

Clarey R. Dowling, MD, P.C. was paid $1.11M by Medicaid between Jan 2018 and Dec 2024, across 63 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 39% of everything it billed.

33Billing provider infoCLAREY R. DOWLING, MD, P.C.
BROWNSVILLE, TN 38012
33aNPI1932363074assigned 07/17/2008
33bProvider typeSpecialist
28Total paid$1.11M
24GClaims238,198
24DCodes billed63
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Specialist providers in Tennessee

Rank by total paid#37 of 252
Median peer was paid$57K
This provider vs. median19×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$10K$20K$30K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201828,953$132K
201941,112$149K
202032,550$120K
202134,788$155K
202238,596$226K
202335,585$202K
2024incomplete26,614$124K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 39% 16,495 12,073 $434K
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 22% 7,700 6,340 $247K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B 19% 2,204 1,857 $215K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 3.2% 4,783 3,754 $35K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 3.1% 8,608 6,869 $35K
87631 2.8% 373 312 $31K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 2.7% 486 431 $30K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 1,339 586 $11K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 318 250 $7K
J1040 Injection, methylprednisolone acetate, 80 mg <1% 1,416 1,182 $6K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 852 719 $6K
90688 <1% 862 779 $6K
51 more codes
1160F <1% 15,357 $4K
1159F <1% 15,426 $4K
J1030 Injection, methylprednisolone acetate, 40 mg <1% 1,309 $4K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 365 $3K
81001 <1% 2,056 $3K
99203 Doctor's office visit, new patient (routine) <1% 56 $3K
71046 Radiologic examination, chest; 2 views <1% 397 $2K
3078F <1% 7,448 $2K
3008F <1% 13,177 $2K
36415 Collection of venous blood by venipuncture <1% 3,200 $2K
3074F <1% 7,187 $2K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 56 $2K
3079F <1% 3,846 $2K
3077F <1% 3,623 $2K
3080F <1% 1,960 $1K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 766 $899.70
3075F <1% 2,409 $838.54
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) <1% 13 $834.60
90756 <1% 92 $809.39
J1010 Injection, methylprednisolone acetate, 1 mg <1% 183 $667.53
81003 <1% 693 $544.80
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 2,231 $486.78
90686 <1% 50 $373.26
93000 <1% 16 $140.45
G0008 Administration of influenza virus vaccine <1% 729 $96.60
82962 <1% 58 $68.40
99308 Subsequent nursing facility care, per day, straightforward <1% 15 $53.30
90694 <1% 43 $2.66
G8417 Bmi is documented above normal parameters and a follow-up plan is documented 0% 12,386 $0.00
G8753 Most recent systolic blood pressure >= 140 mmhg 0% 4,570 $0.00
G8752 Most recent systolic blood pressure < 140 mmhg 0% 11,773 $0.00
G8427 Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications 0% 20,099 $0.00
4004F 0% 4,881 $0.00
1158F 0% 109 $0.00
90662 0% 19 $0.00
90653 0% 15 $0.00
G9902 Patient screened for tobacco use and identified as a tobacco user 0% 4,688 $0.00
1036F 0% 13,236 $0.00
G8754 Most recent diastolic blood pressure < 90 mmhg 0% 13,725 $0.00
G9906 Patient identified as a tobacco user received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy) 0% 4,661 $0.00
99000 0% 169 $0.00
G9903 Patient screened for tobacco use and identified as a tobacco non-user 0% 12,456 $0.00
G8420 Bmi is documented within normal parameters and no follow-up plan is required 0% 4,331 $0.00
G8755 Most recent diastolic blood pressure >= 90 mmhg 0% 2,412 $0.00
3044F 0% 29 $0.00
G9664 Patients who are currently statin therapy users or received an order (prescription) for statin therapy 0% 109 $0.00
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit 0% 96 $0.00
4010F 0% 47 $0.00
1170F 0% 114 $0.00
1126F 0% 34 $0.00
3061F 0% 42 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialDOWLING, CLAREY (REGISTERED AGENT/ PRESIDENT)